ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Eli Lilly and Co

Eli Lilly and Co (LLY)

767.76
10.22
(1.35%)
At close: December 20 4:00PM
775.29
7.53
( 0.98% )
After Hours: 5:12PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
775.29
Bid
-
Ask
-
Volume
9,489,885
766.61 Day's Range 809.44
567.02 52 Week Range 972.53
Market Cap
Previous Close
757.54
Open
808.40
Last Trade
1
@
774.89
Last Trade Time
17:12:34
Financial Volume
$ 7,468,696,553
VWAP
787.0166
Average Volume (3m)
3,675,472
Shares Outstanding
949,315,694
Dividend Yield
0.77%
PE Ratio
139.08
Earnings Per Share (EPS)
5.52
Revenue
34.12B
Net Profit
5.24B

About Eli Lilly and Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology. Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer; Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
Headquarters
Indianapolis, Indiana, USA
Founded
-
Eli Lilly and Co is listed in the Pharmaceutical Preparations sector of the New York Stock Exchange with ticker LLY. The last closing price for Eli Lilly was $757.54. Over the last year, Eli Lilly shares have traded in a share price range of $ 567.02 to $ 972.53.

Eli Lilly currently has 949,315,694 shares outstanding. The market capitalization of Eli Lilly is $719.14 billion. Eli Lilly has a price to earnings ratio (PE ratio) of 139.08.

Eli Lilly (LLY) Options Flow Summary

Overall Flow

Bearish

Net Premium

-12M

Calls / Puts

109.71%

Buys / Sells

96.59%

OTM / ITM

64.51%

Sweeps Ratio

1.28%

LLY Latest News

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity

FDA approves Zepbound® (tirzepatide) as the first and only prescription medicine for moderate-to-severe obstructive sleep apnea in adults with obesity PR Newswire INDIANAPOLIS, Dec. 20, 2024...

Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease

Lilly's Kisunla™ (donanemab-azbt) Approved in China for the Treatment of Early Symptomatic Alzheimer's Disease PR Newswire INDIANAPOLIS, Dec. 17, 2024 China is the fourth major market where...

Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt

Lilly and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt PR Newswire INDIANAPOLIS and CAIRO, Dec. 17, 2024 This milestone stems from the companies...

Lilly's Omvoh® (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn's disease

Lilly's Omvoh® (mirikizumab) recommended by CHMP for approval in the European Union for adults with moderately to severely active Crohn's disease PR Newswire INDIANAPOLIS, Dec. 13, 2024 The Phase...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-5.434-0.696020616761780.724799.7826752.3953530136773.15994692CS
421.292.82360742706754846.4629740.013417240787.67071499CS
12-119.71-13.3754189944895937711.40013675472817.4624339CS
26-116.39-13.0528889288891.68972.53711.40013401682854.26757874CS
52199.8734.7346286191575.42972.53567.023143150801.70444552CS
156506.06187.965679902269.23972.53231.873027740529.14356373CS
260642.8485.168691977132.49972.53116.553279313372.45525342CS

LLY - Frequently Asked Questions (FAQ)

What is the current Eli Lilly share price?
The current share price of Eli Lilly is $ 775.29
How many Eli Lilly shares are in issue?
Eli Lilly has 949,315,694 shares in issue
What is the market cap of Eli Lilly?
The market capitalisation of Eli Lilly is USD 719.14B
What is the 1 year trading range for Eli Lilly share price?
Eli Lilly has traded in the range of $ 567.02 to $ 972.53 during the past year
What is the PE ratio of Eli Lilly?
The price to earnings ratio of Eli Lilly is 139.08
What is the cash to sales ratio of Eli Lilly?
The cash to sales ratio of Eli Lilly is 21.36
What is the reporting currency for Eli Lilly?
Eli Lilly reports financial results in USD
What is the latest annual turnover for Eli Lilly?
The latest annual turnover of Eli Lilly is USD 34.12B
What is the latest annual profit for Eli Lilly?
The latest annual profit of Eli Lilly is USD 5.24B
What is the registered address of Eli Lilly?
The registered address for Eli Lilly is 334 NORTH SENATE AVENUE, INDIANAPOLIS, INDIANA, 46204
What is the Eli Lilly website address?
The website address for Eli Lilly is www.lilly.com
Which industry sector does Eli Lilly operate in?
Eli Lilly operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
STEMStem Inc
$ 0.3488
(7.72%)
2.22M
QBTSD Wave Quantum Inc
$ 6.8601
(6.52%)
1.16M
MPLNChurchill Capital Corp III
$ 6.32
(4.98%)
1.52k
CARSCars com Inc
$ 18.33
(4.98%)
240.65k
CANGCango Inc
$ 5.30
(4.95%)
2.09k
ZKHZKH Group Limited
$ 3.41
(-7.84%)
1.9k
NEXANexa Resources SA
$ 7.29
(-7.49%)
1.34k
SRFMSurf Air Mobility Inc
$ 3.08
(-6.95%)
4.17k
GICGlobal Industrial Company
$ 23.50
(-6.75%)
3.34k
ELMEElme Communities
$ 14.14
(-5.61%)
120.67k
APOApollo Global Management Inc
$ 170.85
(-0.11%)
24.89M
KRKroger Co
$ 62.10
(0.40%)
11.18M
BACBank of America Corporation
$ 44.17
(0.00%)
4.33M
TAT&T Inc
$ 22.70
(-0.22%)
4.3M
WFCWells Fargo and Company
$ 70.33
(-0.01%)
4.12M

LLY Discussion

View Posts
fung_derf fung_derf 3 weeks ago
I've been waiting and waiting for this one to pull back and it has. However, it is fighting mightily to hold support here....Right now I'm thinking it looks moderately hopeful here, but I think $NVO has become the better play now.
👍️0
Saving Grace Saving Grace 2 months ago
Industry changing direction. Big Pharma going south! LLY a major short candidate going into 2025.
👍️0
TechandBio TechandBio 2 months ago
$1000 strikes for Jan 2025 look juicy.

$LLY
👍️0
uksausage uksausage 3 months ago
why?
👍️0
Saving Grace Saving Grace 3 months ago
Big Pharma to crash hard. Be prepared!
👍️0
TechandBio TechandBio 3 months ago
Wonder if Lily Buys SMMT.
$LLY
👍️0
DewDiligence DewDiligence 4 months ago
LLY offers Zepbound in_single-use_vials_at_sharply_reduced_prices—(yesterday’s news):

https://www.nytimes.com/2024/08/27/well/eli-lilly-zepbound-price.html On Tuesday, Eli Lilly announced that it would start selling low doses of its weight-loss drug Zepbound in vials… — at a far lower price than its pens, which come with pre-filled doses. These vials will be made available only through LillyDirect, a telehealth platform the company launched in January (https://investor.lilly.com/news-releases/news-release-details/lilly-launches-end-end-digital-healthcare-experience-through ).

…The vials are significantly cheaper than Zepbound pens, which cost just over $1,000 a month without insurance. A month’s supply of the 2.5-milligram dose will cost $399, and a month’s worth of the five-milligram dose will cost $549.

… The company will offer vials with only the two lowest doses of Zepbound. Many patients stay on a five milligram dose… but some gradually increase their dose, up to a maximum of 15 milligrams. Any patient interested in taking more than the five-milligram dose would have to transition to the pens.

…the move could help Lilly regain customers who are currently getting compounded tirzepatide, which typically costs between roughly $250 and $450 a month. Why would anyone want a compounded formulation of tirzepatide derived from Chinese API when they can get the real thing from LLY at close to the same price?
👍️0
Monksdream Monksdream 4 months ago
LLY new 52=week high
👍️0
EnchantedTitan62 EnchantedTitan62 4 months ago
To quote Areosmith ' I'm back in the saddle again' . 💰
👍️0
EnchantedTitan62 EnchantedTitan62 4 months ago
In the green premarket again. 🍷
👍️0
EnchantedTitan62 EnchantedTitan62 4 months ago
Bought back in at open today. 🍷
👍️0
EnchantedTitan62 EnchantedTitan62 4 months ago
In regards to new a pharma product.
👍️0
SantaZar SantaZar 4 months ago
$LLY Chart from #DDAmanda - #1 Stock Screener :



Z
👍️0
EnchantedTitan62 EnchantedTitan62 4 months ago
Just sold my LLY shares. Wonderful way to ease into the weekend. Good luck to everyone today.
👍️0
EnchantedTitan62 EnchantedTitan62 4 months ago
Added @ $866.29
👍️0
EnchantedTitan62 EnchantedTitan62 4 months ago
Going to be another green day.
👍️0
EnchantedTitan62 EnchantedTitan62 4 months ago
I don't think they have sales in Europe yet, that'll change. 💰💰💰
👍️0
EnchantedTitan62 EnchantedTitan62 4 months ago
Uh, probably not .
👍️0
Monksdream Monksdream 5 months ago
LLY new 52=week high
👍️0
EL Sueno EL Sueno 5 months ago
Let's go fans 1000.00!!!
👍️0
Monksdream Monksdream 6 months ago
LLY new 52 week high
👍️0
Monksdream Monksdream 6 months ago
LLY new 52 week high
👍️0
Monksdream Monksdream 8 months ago
LLY 10Q due 4/30
Next day setttlement begins 5/28
👍️0
north40000 north40000 9 months ago
FDA advises LLY it wants AdCom meeting. Portends delay. Meanwhile NVO CEO was interviewed on CNBC-TV this morning, repeats NVO’s PR warning dated in January 2024 that it will not have manufacturing capacity to fill demand for its weight loss drug until 2006(?).
👍️0
Alfonz66 Alfonz66 9 months ago
Sell now boys you had a great run
👍️0
Monksdream Monksdream 10 months ago
LLY new 52 week high
👍️0
Monksdream Monksdream 10 months ago
LLY new 52 week high

👍️0
oldstocks oldstocks 10 months ago
Eli Lilly was investigating Talampanel prior to 2010

For the treatment of epilepsy, malignant gliomas and ALS
development codes LY-300164 , LY300164
results from the trial for ALS have been found negative
Talampanel is not currently under development.
It showed effectiveness for epilepsy in clinical trials but its development was suspended due to its poor pharmacokinetic profile, namely a short terminal half-life (3 hours) that necessitated multiple doses per day.
RespireRx Pharmaceuticals $ RSPI a little unknown company KRM–II–81 has shown promising results for Epilepsy.
Has fully suppressed the epileptiform activity in the excised brain tissue from a 19-year-old patient with pharmaco-resistant epilepsy.
👍️0
ralphey ralphey 10 months ago
I bought Lilly about a year ago based on Mounjaro and knowing it was going to be a success. I am a FAmily Doc who has done bariatric medicine for 30 years. Zepbound definitely is inducing more weight loss than Ozempic (Wegovy) but I am getting concerned over the number of patients that are stopping zepbound / Mounjaro due to side effects, seems a lot more than on Ozempic ( Wegovy) .
👍️0
Monksdream Monksdream 10 months ago
Incredible, isn’t it
What gets me about these social media bozos is they actually believe they will become Boca Raton rich by day trading sub $1 stocks
Because they are incapable of researching companies
🌈 1 🍆 1
vinsterr vinsterr 10 months ago
800$ tomorrow?
👍️0
Monksdream Monksdream 11 months ago
LLY new 52=week high
👍️0
Monksdream Monksdream 11 months ago
LLY new 52 week high
👍️0
Monksdream Monksdream 11 months ago
LLY new 52 week high
👍️0
Monksdream Monksdream 12 months ago
LLY new 52 week high
🍆 1
lvhd lvhd 1 year ago
Shorted at 625.
👍️0
golfndude golfndude 1 year ago
Great news on their new diabetes drug.
👍️0
peanutz peanutz 1 year ago
Looking for the bottom ,not yet :)
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 year ago
Amazing financials
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 year ago
Billionaires dream a while back, speculating
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 year ago
Interesting company
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 year ago
Wowwwwwww
👍️0
TRUSTUNITS1000000 TRUSTUNITS1000000 1 year ago
Knew this company from the 80 ssssss
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0
lvhd lvhd 1 year ago
Who is pumping?
👍️0
Monksdream Monksdream 1 year ago
LLY new 52 week high
👍️0
1jas 1jas 1 year ago
anyone here, hear enzc announced they now have a CURE for hiv/aids clone 3, yesterday on accesswire and yahoo finance.
👍️0
1jas 1jas 1 year ago
anyone here, hear enzc announced they now have a CURE for hiv/aids clone 3, yesterday on accesswire and yahoo finance.
👍️0
1jas 1jas 1 year ago
anyone here, hear enzc announced they now have a CURE for hiv/aids clone 3, yesterday on accesswire and yahoo finance.
👍️0

Your Recent History

Delayed Upgrade Clock